IL7R and acute lymphoblastic leukemia: Gain-of-function mutations in interleukin-7 receptor-α conferring cytokine-independent growth of progenitor lymphoid cells were first described by Shochat and colleagues [46, 47] and shown to be involved in human T-cell leukemogenesis [48] and drug resistance in T-ALL [49].